PUBLIC COMPANY
saveImplicit Bioscience Ltd
updated 2mo ago
community read0 votes
🐶 often sniffed alongside
top 3pipeline
1
marketed
0
phase 3
0
catalysts ytd
1
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Unknown
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2Anti-CD14 Treatment With IC14 in Hospitalized ARDS Patients
- phase2IC14 in Adult Patients With Dengue Fever
- phase2IC14 for Rapidly Progressive Amyotrophic Lateral Sclerosis (ALS)
- phase2IC14 (Atibuclimab) in Arrhythmogenic Cardiomyopathy
- phase2Pilot Study of IC14 (Atibuclimab), an Anti-CD14 Monoclonal Antibody, to Treat STEMI
- phase2IC14 for Treatment of Acute Decompensated Heart Failure
- phase2A Phase 2 Study of IC14 in Acute Respiratory Distress Syndrome
- —IC14 for ALS Patients Expanded Access
🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that